Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Times Interest Earned (2017 - 2025)

Updated

Adaptimmune Therapeutics' (ADAPY) Times Interest Earned stood at -31.48 in Q2 2025, compared with 130.61 a year earlier.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Times Interest Earned (2017 - 2025) Analysis & Trends

On a TTM basis, Adaptimmune Therapeutics' Times Interest Earned came in at -28.99 as of Jun 30, 2025; for FY2024, it was -20.54.

  • Quarterly Times Interest Earned has ranged from -42.92 in Q4 2024 to 130.61 in Q2 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -24.31 (Q1 2025), -42.92 (Q4 2024) and -13.24 (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -31.48
Mar 31, 2025 -24.31
Dec 31, 2024 -42.92
Sep 30, 2024 -13.24
Jun 30, 2024 130.61
Sep 30, 2017 -620.00
Jun 30, 2017 -3,963.33
API Access

Adaptimmune Therapeutics PLC Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=ADAPY&period=max&api_key=YOUR_API_KEY